Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells
Author Information
Author(s): Anumanthan G, Halder S K, Osada H, Takahashi T, Massion P P, Carbone D P, Datta P K
Primary Institution: Vanderbilt University School of Medicine
Hypothesis
Loss of TGF-β receptor expression may contribute to lung tumor progression.
Conclusion
Restoring TGF-β signaling by reintroducing TβRII in lung cancer cells reduces their tumorigenicity.
Supporting Evidence
- 65% of NSCLC samples showed downregulation of TβRII.
- 77% of tumor samples had reduced TβRII protein levels.
- Stable expression of TβRII restored TGF-β signaling in lung cancer cells.
- TβRII expression reduced colony formation in soft-agarose assays.
- TβRII expression decreased tumorigenicity in athymic nude mice.
Takeaway
Scientists found that adding a missing part of a cell's signaling system can help stop cancer cells from growing and spreading.
Methodology
The study involved RT–PCR and Western blot analyses of lung cancer tissues and experiments with a lung adenocarcinoma cell line.
Potential Biases
Potential bias in sample selection and the specific cell line used for experiments.
Limitations
The study primarily focused on a specific cell line and may not fully represent all lung cancer types.
Participant Demographics
Patients with non-small-cell lung cancer (NSCLC) who had not received prior treatment.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website